Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Respiratory therapeutics Market Research Reports

Titlepublishedprice

Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ve of the Dyspnea Report is to understand the market and pipeline status of the drugs around the Dyspnea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The......"
01-Sep-2016$2000

Bronchitis  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bronchitis forecasted market share for ten years to 2023 segmented by seven major ma......"
01-Sep-2016$4950

Chronic Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Chronic Bronchitis Report is to understand the market and pipeline status of the drugs around the Chronic Bronchitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on d......"
01-Sep-2016$2000

Chronic Obstructive Pulmonary Disease (COPD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... urers across the globe. A key objective of the Chronic Obstructive Pulmonary Disease (COPD) Report is to understand the market and pipeline status of the drugs around the Chronic Obstructive Pulmonary Disease (COPD) to explore the generic development......"
01-Sep-2016$2000

Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ss the globe. A key objective of the Lower Respiratory Tract Infections Report is to understand the market and pipeline status of the drugs around the Lower Respiratory Tract Infections to explore the generic development opportunities, licensing oppo......"
01-Sep-2016$2000

Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... globe. A key objective of the Respiratory Tract Infections Report is to understand the market and pipeline status of the drugs around the Respiratory Tract Infections to explore the generic development opportunities, licensing opportunities and to g......"
01-Sep-2016$2000

Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... e globe. A key objective of the Respiratory Distress Syndrome Report is to understand the market and pipeline status of the drugs around the Respiratory Distress Syndrome to explore the generic development opportunities, licensing opportunities and t......"
01-Sep-2016$2000

Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... globe. A key objective of the Respiratory Hypersensitivity Report is to understand the market and pipeline status of the drugs around the Respiratory Hypersensitivity to explore the generic development opportunities, licensing opportunities and to g......"
01-Sep-2016$2000

Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... urers across the globe. A key objective of the Respiratory Syncytial Virus (RSV) Infections Report is to understand the market and pipeline status of the drugs around the Respiratory Syncytial Virus (RSV) Infections to explore the generic development......"
01-Sep-2016$2000

Upper Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ss the globe. A key objective of the Upper Respiratory Tract Infections Report is to understand the market and pipeline status of the drugs around the Upper Respiratory Tract Infections to explore the generic development opportunities, licensing oppo......"
01-Sep-2016$2000